HydroquinonevsMandelic Acid

Hydroquinone inhibits tyrosinase through multiple mechanisms: competitive alternative substrate, oxidation to semiquinone radicals generating ROS that damage melanocyte mitochondria and ER, copper chelation at tyrosinase active site. Inhibits RNA/DNA synthesis via ribonucleotide reductase interference. Causes melanosome degradation through membrane disruption. Dramatic melanin reduction — eumelanin and pheomelanin pathways suppressed. Selectively affects hyperactive melanocytes, sparing quiescent ones. Fades pigmentation without permanently altering baseline skin color. Pigmentation returns when treatment stops (melanocyte stem cells intact). Enhanced with retinoids (penetration) and sunscreen (prevents UV rebound).

Mandelic acid (152 Da, the largest common AHA) exfoliates through calcium chelation and corneodesmosome disruption like other AHAs, but its large molecular size results in slower, more even epidermal penetration with reduced risk of hot-spot irritation and stratum corneum over-exfoliation. Its phenyl ring confers partial lipophilicity, enabling penetration into the pilosebaceous unit and follicular infundibulum—unlike purely hydrophilic glycolic and lactic acids. Within pores, mandelic acid exerts mild comedolytic effects by disrupting keratinocyte cohesion in the follicular epithelium, similar to salicylic acid. It demonstrates antibacterial activity against Cutibacterium acnes (Propionibacterium acnes) through membrane disruption. Mandelic acid also inhibits tyrosinase and reduces melanosome transfer to keratinocytes, providing brightening benefits. This profile makes it particularly suitable for acne-prone skin, hyperpigmentation, and darker skin tones (Fitzpatrick IV–VI) where gentler exfoliation minimizes post-inflammatory hyperpigmentation risk.